Nebulizer Market Size, Share & Trends Analysis Report By Type (Pneumatic, Ultrasonic, Mesh), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2019 - 2026

Industry Insights

The global nebulizer market size was valued at USD 870.1 million in 2018 and is expected to expand at a CAGR of 6.5% over the forecast period. High prevalence of chronic respiratory diseases, increasing demand for home healthcare, and rising geriatric population across the globe are some of the major factors driving the growth. Technological advancements are anticipated to further fuel the growth.

High prevalence of chronic diseases is one of the major driving factors for the market growth. For instance, as per the Global Burden of Disease Study, an estimated 251 million people worldwide were suffering from Chronic Obstructive Pulmonary Disease (COPD) in 2016. In addition, as per the World Health Organization (WHO), around 3.17 million deaths were reported due to COPD in 2015.

Initiatives such as the Global Alliance against Chronic Respiratory Diseases are likely to improve diagnosis and treatment rates of respiratory disorders, which may in turn boost the nebulizer market. Furthermore, as per a 2015 report by WHO, each year 16 million people die due to non-communicable diseases before the age of 70.

In addition, factors such as rise in obesity, unhealthy eating habits, lack of physical activity, and overconsumption of tobacco and alcohol are also likely to lead to high prevalence of respiratory disorders. This factor may contribute to growth of the market over the forecast period.

Type Insights

Based on type, the market is trifurcated into pneumatic, mesh, and ultrasonic nebulizer. The pneumatic and ultrasonic nebulizer segments are sub-segmented into standalone and portable. Pneumatic nebulizer held a dominant share in 2018 owing to the high prevalence of respiratory disorders among aging population.

Mesh nebulizer segment is expected to witness the fastest growth over the forecast period. These products can be static as well as vibrating. Static mesh nebulizer apply a force on the liquid drug to push it through a static mesh, whereas in vibrating mesh nebulizer use mesh vibration or deformation to push the liquid drug through the mesh. Some of the products offered by the key players in the market are Omron Corporation’s MicroAIR U100, Allied Healthcare’s Schuco S5000 Nebulizer, and Philips Healthcare’s Aeroneb Go.

Regional Insights

North America accounted for the largest market share in 2018 and is estimated to witness significant growth over the forecast period, owing to the rise in incidence of chronic respiratory diseases. According to the Centers for Disease Control and Prevention (CDC), COPD was estimated as the third leading causes of death in U.S. in 2014. Moreover, rise in geriatric population in North America is resulting into rising number of respiratory disorders and surgeries, which is also likely to boost the regional growth.According to Statistics Canada, in July 2015, approximately 16.1% of the population was aged 65 years and over. In addition, healthcare cost containment issues post the economic crisis in U.S. have compelled the government to introduce new strategies to reduce patient stays in hospitals and hospital readmissions. This has resulted into increase in homecare services, which, in turn, has created a favorable environment for the growth.

Asia Pacific region is expected to exhibit the fastest CAGR during the forecast period due to rising geriatric population and cases of respiratory diseases. COPD is the seventh most common cause of death in Japan according to Japan’s Ministry of Health, Labor and Welfare. In addition, according to the Institute for Health Metrics and Evaluation, in Japan, COPD cases increased by 24.2% from 2005 to 2016. Moreover, a significant percentage of population of countries such as India and China has been estimated to suffer from pulmonary diseases. According to the WHO, in 2017, around 90.0% of deaths resulting from COPD occurred in middle- and low-income countries. It also stated that countries, such as China and India, single-handedly accounted for about 66.0% of total mortality resulting from COPD. Thus, such high number of cases of respiratory diseases is expected to boost the regional market. Rise in healthcare expenditure and patient awareness is also anticipated to propel the growth.

Nebulizer Market Share Insights

Prominent key players include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; and Allied Healthcare Products, Inc. Key players are involved in adopting various strategies such as mergers and acquisitions, product launches, and partnerships to strengthen their market position.

In June 2016, PARI Pharma eFlow technology was used in two pivotal phase III trials of SUN-101. By pairing with SUN-101 and eFlow technology, Sunovion intends to combine the attributes of an inhaler and a nebulizer in a single system.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented nebulizer market on the basis of type and region:

• Type Outlook (Revenue, USD Million; 2015 - 2026)

  • Pneumatic

    • Standalone

    • Portable

  • Mesh

  • Ultrasonic

    • Standalone

    • Portable

• Regional Outlook (Revenue, USD Million; 2015 - 2026)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • Greece

    • Italy

    • Poland

    • France

  • Asia Pacific

    • Japan

    • China

    • India

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE